21 CFR Part 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- Subpart A - General Provisions (§§ 212.1 - 212.5)
- Subpart B - Personnel and Resources (§ 212.10)
- Subpart C - Quality Assurance (§ 212.20)
- Subpart D - Facilities and Equipment (§ 212.30)
- Subpart E - Control of Components, Containers, and Closures (§ 212.40)
- Subpart F - Production and Process Controls (§ 212.50)
- Subpart G - Laboratory Controls (§§ 212.60 - 212.61)
- Subpart H - Finished Drug Product Controls and Acceptance (§§ 212.70 - 212.71)
- Subpart I - Packaging and Labeling (§ 212.80)
- Subpart J - Distribution (§ 212.90)
- Subpart K - Complaint Handling (§ 212.100)
- Subpart L - Records (§ 212.110)
Authority:
Source:
74 FR 65431, Dec. 10, 2009, unless otherwise noted.
{'United States Code': [{'Title': '21', 'Section': '321', 'headtext': ' Definitions; generally', 'cleanpath': '/uscode/text/21/321'}, {'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '355', 'headtext': ' New drugs', 'cleanpath': '/uscode/text/21/355'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}, {'Title': '21', 'Section': '374', 'headtext': ' Inspection', 'cleanpath': '/uscode/text/21/374'}], 'Statutes at Large': [{'Volume': '111', 'Page': '2296', 'headtext': '111 Stat. 2296', 'cleanpath': 'https://www.law.cornell.edu/rio/citation/111_Stat._2296'}], 'Public Laws': [], 'Presidential Documents': []}